Diseases, Conditions, Syndromes

Protein study may be key to treating fibrotic diseases

A protein linked to amyotrophic lateral sclerosis (ALS), a progressive neurological disease that causes muscle weakness, may be a key to treating fibrotic disease of the kidneys and other organs, researchers at Vanderbilt ...

Neuroscience

Stem cell 'therapy' injuries more widespread than we knew

Grotesque side effects from unproven 'stem cell' therapies are more common than we realized, reports a team of researchers led by UConn Health in Annals of Neurology on July 29. And despite the dangers, many neurologists ...

Genetics

In a severe childhood neurodegeneration, novel mechanism found

Neurology researchers investigating a rare but devastating neurological regression in infants have discovered the cause: gene mutations that severely disrupt crucial functions in mitochondria, the energy-producing structures ...

Genetics

What percentage of ALS is genetic?

Up to 90 percent of people with amyotrophic lateral sclerosis (ALS) report that they have no family history of the disease. Now, new research has found approximately 17 percent of such ALS cases may be caused by a gene mutation, ...

Neuroscience

Cannabis constituent has no effect on MS progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that ...

Alzheimer's disease & dementia

Seizures late in life may be an early sign of Alzheimer's disease

Patients with epilepsy who had amnestic mild cognitive impairment (aMCI) or Alzheimer disease (AD) presented earlier with cognitive decline than patients who did not have epilepsy, according to a report published by JAMA ...

page 1 from 3